- Home
- FTI vs NBIX Comparison
FTI vs NBIX Comparison
Compare FTI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- NBIX
- Stock Information
- Founded
- FTI 1884
- NBIX 1992
- Country
- FTI United States
- NBIX United States
- Employees
- FTI N/A
- NBIX N/A
- Industry
- FTI Metal Fabrications
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTI Industrials
- NBIX Health Care
- Exchange
- FTI Nasdaq
- NBIX Nasdaq
- Market Cap
- FTI 10.9B
- NBIX 11.0B
- IPO Year
- FTI N/A
- NBIX 1996
- Fundamental
- Price
- FTI $29.87
- NBIX $115.71
- Analyst Decision
- FTI Strong Buy
- NBIX Strong Buy
- Analyst Count
- FTI 13
- NBIX 20
- Target Price
- FTI $36.33
- NBIX $163.20
- AVG Volume (30 Days)
- FTI 4.6M
- NBIX 1.9M
- Earning Date
- FTI 04-24-2025
- NBIX 05-05-2025
- Dividend Yield
- FTI 0.67%
- NBIX N/A
- EPS Growth
- FTI 393.36
- NBIX N/A
- EPS
- FTI 1.96
- NBIX 2.96
- Revenue
- FTI $9,295,000,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- FTI $9.16
- NBIX $15.36
- Revenue Next Year
- FTI $6.51
- NBIX $16.34
- P/E Ratio
- FTI $15.27
- NBIX $39.13
- Revenue Growth
- FTI 14.03
- NBIX 21.73
- 52 Week Low
- FTI $22.12
- NBIX $84.23
- 52 Week High
- FTI $33.45
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- FTI 60.30
- NBIX 60.88
- Support Level
- FTI $28.91
- NBIX $105.45
- Resistance Level
- FTI $29.73
- NBIX $130.46
- Average True Range (ATR)
- FTI 0.89
- NBIX 4.31
- MACD
- FTI 0.36
- NBIX 1.96
- Stochastic Oscillator
- FTI 91.75
- NBIX 50.22
About FTI TechnipFMC plc
TechnipFMC is the largest pure-play offshore oilfield service provider, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea engineering and construction services. The company also provides various surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of predecessor companies Technip and FMC Technologies.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.